View in EDS HTML Full Text

Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Naïve Patients.

Saved in:
Bibliographic Details
Title: Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Naïve Patients.
Authors: Halahleh K; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan. Electronic address: Kh.06314@khcc.jo., Al Sawajneh S; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Saleh Y; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Shahin O; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Abufara A; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Ma'koseh M; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Abdel-Razeq R; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Barakat F; Department of Hematopathology, King Hussein Cancer Center, Amman, Jordan., Abdelkhaleq H; Biostatistics Unit, Research Office, King Hussein Cancer Center, Amman, Jordan., Al-Hassan N; Department of Nursing, King Hussein Cancer Center, Amman, Jordan., Atiyyat R; Department of Nursing, King Hussein Cancer Center, Amman, Jordan., Al-Faker N; Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan., Omari Z; Department of Radiology, King Hussein Cancer Center, Amman, Jordan., Ghatasheh H; Department of Radiotherapy, King Hussein Cancer Center, Amman, Jordan., Jaradat I; Department of Radiotherapy, King Hussein Cancer Center, Amman, Jordan., Muradi I; Department of Medicine, University of Tripoli, Tripoli, Libya., Iyad S; Department of Pediatrics, Medical Oncology-Hematology, King Hussein Cancer Center, Amman, Jordan., Bazarbachi A; Bone Marrow Transplantation Department, American University of Beirut, Beirut, Lebanon.
Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Aug; Vol. 22 (8), pp. 589-595. Date of Electronic Publication: 2022 Mar 04.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35490153
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Naïve Patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Halahleh+K%22">Halahleh K</searchLink>; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan. Electronic address: Kh.06314@khcc.jo.<br /><searchLink fieldCode="AU" term="%22Al+Sawajneh+S%22">Al Sawajneh S</searchLink>; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Saleh+Y%22">Saleh Y</searchLink>; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Shahin+O%22">Shahin O</searchLink>; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Abufara+A%22">Abufara A</searchLink>; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Ma'koseh+M%22">Ma'koseh M</searchLink>; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Abdel-Razeq+R%22">Abdel-Razeq R</searchLink>; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Barakat+F%22">Barakat F</searchLink>; Department of Hematopathology, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Abdelkhaleq+H%22">Abdelkhaleq H</searchLink>; Biostatistics Unit, Research Office, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Al-Hassan+N%22">Al-Hassan N</searchLink>; Department of Nursing, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Atiyyat+R%22">Atiyyat R</searchLink>; Department of Nursing, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Al-Faker+N%22">Al-Faker N</searchLink>; Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Omari+Z%22">Omari Z</searchLink>; Department of Radiology, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Ghatasheh+H%22">Ghatasheh H</searchLink>; Department of Radiotherapy, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Jaradat+I%22">Jaradat I</searchLink>; Department of Radiotherapy, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Muradi+I%22">Muradi I</searchLink>; Department of Medicine, University of Tripoli, Tripoli, Libya.<br /><searchLink fieldCode="AU" term="%22Iyad+S%22">Iyad S</searchLink>; Department of Pediatrics, Medical Oncology-Hematology, King Hussein Cancer Center, Amman, Jordan.<br /><searchLink fieldCode="AU" term="%22Bazarbachi+A%22">Bazarbachi A</searchLink>; Bone Marrow Transplantation Department, American University of Beirut, Beirut, Lebanon.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101525386%22">Clinical lymphoma, myeloma & leukemia</searchLink> [Clin Lymphoma Myeloma Leuk] 2022 Aug; Vol. 22 (8), pp. 589-595. <i>Date of Electronic Publication: </i>2022 Mar 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525386 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-2669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221522669%22">21522669 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lymphoma Myeloma Leuk <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35490153
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clml.2022.02.009
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 589
    Titles:
      – TitleFull: Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Naïve Patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Halahleh K
      – PersonEntity:
          Name:
            NameFull: Al Sawajneh S
      – PersonEntity:
          Name:
            NameFull: Saleh Y
      – PersonEntity:
          Name:
            NameFull: Shahin O
      – PersonEntity:
          Name:
            NameFull: Abufara A
      – PersonEntity:
          Name:
            NameFull: Ma'koseh M
      – PersonEntity:
          Name:
            NameFull: Abdel-Razeq R
      – PersonEntity:
          Name:
            NameFull: Barakat F
      – PersonEntity:
          Name:
            NameFull: Abdelkhaleq H
      – PersonEntity:
          Name:
            NameFull: Al-Hassan N
      – PersonEntity:
          Name:
            NameFull: Atiyyat R
      – PersonEntity:
          Name:
            NameFull: Al-Faker N
      – PersonEntity:
          Name:
            NameFull: Omari Z
      – PersonEntity:
          Name:
            NameFull: Ghatasheh H
      – PersonEntity:
          Name:
            NameFull: Jaradat I
      – PersonEntity:
          Name:
            NameFull: Muradi I
      – PersonEntity:
          Name:
            NameFull: Iyad S
      – PersonEntity:
          Name:
            NameFull: Bazarbachi A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2152-2669
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Clinical lymphoma, myeloma & leukemia
              Type: main
ResultId 1